Literature DB >> 21288225

Comparison of four pain scales in patients with hip fracture or other lower limb trauma.

K A Leino1, K S Kuusniemi, K K Lertola, K T Olkkola.   

Abstract

BACKGROUND: The applicability of the Visual Analogue Scale (VAS) has been questioned in the assessment of pain in the elderly. We compared VAS with three other pain scales, Verbal Rating Scale (VRS), Red Wedge Scale (RWS) and Box Scale (BS), in hip fracture patients.
METHODS: VAS, VRS, RWS and BS were compared in 140 analysable patients undergoing surgery, 70 with hip fracture and 70 with other lower limb trauma. Pain scores were recorded once a day, repeated after 10 min, for 4 subsequent days starting pre-operatively. The primary endpoint was the rate of successful pain measurements in hip fracture patients and 90% was chosen as a sufficient level for an applicable pain scale.
RESULTS: Age was different between the groups (hip fracture 78 ± 11, other trauma 49 ± 11 years, P<0.0001). In hip fracture patients, 67-83% of pain measurements were successful with VAS, 82-100% with VRS, 83-96% with RWS and 79-91% with BS. The success rate with VAS was significantly <90% on 2 days (P<0.0001) and with BS on 1 day (P=0.04). All the other success rates with the four scales in both groups were above or not different from 90%.
CONCLUSION: VRS and RWS were the most applicable scales, unlike VAS, which appeared to be an unreliable pain scale in perioperative hip fracture patients. In patients with other lower limb trauma, all four scales provided excellent applicability. Our results are in accordance with the accumulating evidence suggesting that VAS is not an ideal tool for pain measurement in the elderly.
© 2011 The Authors. Acta Anaesthesiologica Scandinavica © 2011 The Acta Anaesthesiologica Scandinavica Foundation.

Entities:  

Mesh:

Year:  2011        PMID: 21288225     DOI: 10.1111/j.1399-6576.2010.02373.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  8 in total

1.  Longitudinal construct validity of the Health Utilities Indices Mark 2 and Mark 3 in hip fracture.

Authors:  C Allyson Jones; Sheri L Pohar; David H Feeny; Ken Eng
Journal:  Qual Life Res       Date:  2013-10-01       Impact factor: 4.147

2.  Association between Acute Postoperative Pain and Recovery of Independent Walking Ability after Surgical Treatment of Hip Fracture.

Authors:  Mitsumasa Hida; Yuko Deguchi; Kazuya Miyaguchi; Masako Nakazono; Naoki Hirata; Rie Nakagawa; Atsushi Kitayama
Journal:  Prog Rehabil Med       Date:  2018-06-23

3.  Using a Wearable Activity Monitor to Accurately Measure Mobility After Surgery for Hip Fractures (MASH)-A Feasibility Study Protocol.

Authors:  James T Berwin; Hamish Macdonald; Tom Fleming; Peter Kempshall; Daniel Engelke
Journal:  Geriatr Orthop Surg Rehabil       Date:  2020-11-12

4.  Feasibility of progressive strength training shortly after hip fracture surgery.

Authors:  Jan Overgaard; Morten T Kristensen
Journal:  World J Orthop       Date:  2013-10-18

5.  The Verbal Rating Scale Is Reliable for Assessment of Postoperative Pain in Hip Fracture Patients.

Authors:  Rune Dueholm Bech; Jens Lauritsen; Ole Ovesen; Søren Overgaard
Journal:  Pain Res Treat       Date:  2015-05-20

6.  Present-day challenges and future solutions in postoperative pain management: results from PainForum 2014.

Authors:  Kristiina Kuusniemi; Reino Pöyhiä
Journal:  J Pain Res       Date:  2016-02-03       Impact factor: 3.133

7.  Factors Associated With Psycho-Cognitive Functions in Patients With Persistent Pain After Surgery for Femoral Neck Fracture.

Authors:  Atsushi Kitayama; Mitsumasa Hida; Hidenobu Takami; Naoki Hirata; Yuko Deguchi; Kazuya Miyaguchi; Masako Nakazono; Rie Nakagawa; Noriyuki Fukumoto; Katsumi Hamaoka
Journal:  J Clin Med Res       Date:  2017-07-27

8.  Feasibility of progressive strength training implemented in the acute ward after hip fracture surgery.

Authors:  Lise Kronborg; Thomas Bandholm; Henrik Palm; Henrik Kehlet; Morten Tange Kristensen
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.